Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-09-03
1995-08-15
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530327, 435 721, 436501, 930 21, A61K 3702, C07K 1500, G01N 33574, G01N 33566
Patent
active
054419352
ABSTRACT:
A 75-85 Kd glycopolypeptide, capable of acting as a receptor for polypeptide of the bombesin type, is isolated from the surface of Swiss 3T3 cells. Certain antagonists and antibodies to the glycopolypeptide are described, the antagonists being of quite different structure to bombesin e.g. .differential.D-Pro.sup.2 [-spantide, .differential.D-Phe.sup.5 [-spantide and position 5 variants thereof. The antagonists and antibodies are of interest medically in that they are able to influence cell proliferation that occurs under the influence of the bombesin-like polypeptides.
REFERENCES:
patent: 4481139 (1984-11-01), Folkers et al.
patent: 5073541 (1991-12-01), Taylor et al.
Proc. Natl. Acad. Sci. USA, vol. 85, No. 6, Mar. 1988, P. J. Woll et al. pp. 1859-1863.
Proc. Natl. Acad. Sci., USA, vol. 82, Nov. 1985, I. Zachary et al. pp. 7616-7620.
The Journal of Biological Chemistry, vol. 262, No. 23, 15 Aug. 1987, The American Society for Biochemistry and Molecular Biology, Inc., (US), R. M. Kris et al. pp. 11215-11220.
Acta Chemica Scandinavica, vol. B40, 1986, K. Folkers et al. pp. 295-302 see table I, No. 1,4,10; table 2, No. 1,3,6; table 7, No. 1.
The Journal of Biological Chemistry, vol. 262, No. 9, 25 Mar. 1987, The American Society of Biological Chemists, Inc., (US), I. Zachary et al. pp. 3947-3950.
Nature, vol. 316, 29 Aug. 1985, F. Cuttitta et al. pp. 823-826, see page 826, column 1, lines 6-16.
Biological Abstracts, vol. 83, D. M. Cirillo et al., abstract No. 66775, & Mol. Cell. Biol. 1986, vol. 6, No. 12, pp. 4641-4649.
Cancer Research Supp., 52 2737-2742 (1992).
Eur. J. Biochem., 27:201-202 (1972).
Layton, et al., (1987) J. Cell. Biochem. vol. O (11) A, p. 32, A140.
Corps, et al., "A Peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin," Biochem. J. 231 (1985), 781-84.
Zacary et al., "A Substance P Antagonist Inhibits Specific Binding and Mitogenic Effects of Vasopressin and Bombesin-Related Peptides in Swiss 3T3 Cells," Biochem. Biophys Res Comm 137:135-141 (1986).
Layton et al., J. Cell Biochem Suppl (11) A:32 (1987).
Jensen et al., Nature 309:61-63 (1984).
Bepler et al., "In Vitro Growth Inhibition Of Human Small Cell . . . ," Cancer Research 47:2371-2375 (1987).
Gazdar et al., "Cell Lines As An Investigational Tool For The Study . . . ," Eur J Cancer Clin Oncol 21:815-824 (1985).
Koros et al., "Stability and Utility of The Unique Human Small Cell Carcinoma Line . . . ," Cancer Res 45:2725-31 (1985).
Rozengurt Enrique
Woll Penella
Zachary Ian
Imperial Cancer Research Technology Ltd.
Woodward Michael P.
LandOfFree
Growth factor receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth factor receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181741